People · Operator
Named in public records as an officer, director or promoter · active 2009–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| VIRxSYS Corp | — | Biotechnology | Series B | $44.6M | $39.7M | 2009 |
Helmer Agersborg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Helmer Agersborg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Turner | 1 | 4 |
| Gerard Fleury | 1 | 2 |
| Robert Ackmann | 1 | 2 |
| James Kehoe | 1 | 1 |
| Prince Zachariah | 1 | 1 |
| Lawrence Michaelis | 1 | 1 |
| John Phair | 1 | 1 |
| Franz Schmadl | 1 | 1 |
| Riku Rautsola | 1 | 1 |
| Franz 2 Schmadl | 1 | 1 |
| John 2 Phair | 1 | 1 |
| Prince 2 Zachariah | 1 | 1 |
| William 2 Sick | 1 | 1 |
| William 2 Turner | 1 | 1 |
| William 2 McIntosh | 1 | 1 |
| William Sick | 1 | 1 |
| William McIntosh | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.